Rajinikanth Ayyathurai
University of Miami
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rajinikanth Ayyathurai.
BJUI | 2007
Mark S. Soloway; Cynthia T. Soloway; Steve K. Williams; Rajinikanth Ayyathurai; Bruce R. Kava; Murugesan Manoharan
To examine the outcome of patients diagnosed with ‘low‐risk’ prostate cancer managed by active surveillance (AS).
BJUI | 2008
Rajinikanth Ayyathurai; Murugesan Manoharan; Alan M. Nieder; Bruce R. Kava; Mark S. Soloway
To report the return of erectile function in 1620 consecutive men after radical retropubic prostatectomy (RRP), chosen by half of men diagnosed with clinically localized prostate cancer, and the goal of which is to completely excise the tumour while preserving continence and erectile function.
BJUI | 2009
Murugesan Manoharan; Rajinikanth Ayyathurai; Mark S. Soloway
To review the outcomes in a large group of patients treated with radical cystectomy (RC) for urothelial cancer (UC) of the bladder, by one surgical team.
Journal of Endourology | 2009
Vincent G. Bird; Robert I. Carey; Rajinikanth Ayyathurai; Victoria Y. Bird
BACKGROUND AND PURPOSE Laparoscopic-guided radiofrequency ablation (LRFA) has been introduced as a minimally invasive nephron-sparing management option for renal tumors. Many patients who desire treatment present with multiple comorbidities, which poses a therapeutic challenge. Our purpose is to determine if multipass LRFA is comparable, in terms of surgical risk and immediate postoperative outcomes, to laparoscopic partial nephrectomy (LPN). PATIENTS AND METHODS A retrospective study identified 36 and 33 patients who underwent LRFA and LPN, respectively. Perioperative demographic data, tumor characteristics, and follow-up data were evaluated. Statistical analysis was performed using the Student t test and chi-square analysis. RESULTS Age, American Society of Anesthesiology score, and Charlson Comorbidity Index were significantly higher in the LRFA group than the LPN group (P < 0.001). Average tumor size was 2.8 cm and 3.1 cm for the LRFA and LPN groups, respectively. There were no significant differences in change between the preoperative and postoperative creatinine/glomerular filtration rate values or perioperative complication rates for the groups. Estimated blood loss and length of stay were significantly lower for the LRFA group than the LPN group (P < 0.05). Follow-up ranged 6 to 23 months and 6 to 58 months for the LRFA and the LPN groups, respectively. There has been no evidence of tumor recurrence in the follow-up period. CONCLUSIONS We present our initial report comparing patients undergoing LRFA v LPN for the management of renal tumors. Our preliminary results with our experience with multipass laparoscopic-guided RFA demonstrate that this technique can be safely used in an elderly, higher risk population. Long-term follow-up is needed to determine oncologic efficacy.
The Journal of Sexual Medicine | 2011
Bruce R. Kava; Prashanth Kanagarajah; Rajinikanth Ayyathurai
INTRODUCTION Revision penile prosthesis surgery has traditionally been associated with a greater risk of postoperative infection than primary implant placement. This has been attributed to the high prevalence of asymptomatic bacteria found surrounding the implant at the time of revision surgery. AIM To validate whether contemporary revision surgery remains associated with a high risk of asymptomatic colonization and postoperative infection. METHODS A comprehensive, prospective database consisting of consecutive patients undergoing primary and revision penile prosthesis surgery at our center was analyzed. MAIN OUTCOME MEASURES The infection risk in primary and revision implant surgery was compared. The prevalence of asymptomatic implant colonization during revision surgery, and whether this was associated with clinical infection was evaluated. The spectrum of bacterial species causing infection in this contemporary single-surgeon series was described. RESULTS One hundred seventeen primary and 72 revision implant recipients were studied. Infection developed in four (3.4%) patients undergoing primary implants, two (4.3%) patients undergoing removal and replacement for mechanical malfunction, and three (12%) patients undergoing rerouting for extrusion (P = 0.26). Intraoperative cultures were positive in 5 (9.8%) of 51 revision patients, none of whom developed infections. Organisms causing infection included Staphylococcus aureus and Enterobacter aerogenes. Unexpectedly, an adjuvant, alcohol-based skin prep in our last 83 patients reduced the infection risk to 1.2%. CONCLUSIONS In our series, the infection risk associated with revision of malfunctioning devices was no greater than primary implant placement. Rerouting was associated with a higher infection risk, likely due to technical factors, and not implant colonization. Less than 10% of our revision implants were colonized, and this had no bearing on the development of a postoperative infection. S. epidermidis was not the most common organism implicated in device infections. Finally, our experience with an adjuvant, alcohol-based skin prep warrants further randomized prospective evaluation.
BJUI | 2007
Rajinikanth Ayyathurai; Pablo Gomez; Tony Luongo; Mark S. Soloway; Murugesan Manoharan
To review the long‐term outcome of prostatic involvement in patients with bladder cancer (BC) treated with radical cystectomy (RC), as urothelial carcinoma (UC) involving the prostate occurs in such patients, and prostatic invasion by UC is by transmural invasion (contiguous), or when UC develops from the epithelium of the prostatic urethra (not contiguous).
Cancer | 2012
Andrew Chi; Samir P. Shirodkar; Diogo O. Escudero; Obi Ekwenna; Travis Yates; Rajinikanth Ayyathurai; Michael Garcia-Roig; Jeffrey Gahan; Murugesan Manoharan; Vincent G. Bird; Vinata B. Lokeshwar
Molecular profiling of renal cell carcinomas (RCCs) may improve the distinction between oncocytoma and malignant RCC subtypes and aid in early detection of metastasis. The hyaluronic acid (HA) family includes HA synthases (HAS1, HAS2, HAS3), hyaluronidases (HYAL‐1, HYAL‐2, HYAL‐3, HYAL‐4, PH20, HYAL‐P1), and HA receptors (CD44s, CD44v, RHAMM). HA family members promote tumor growth and metastasis. The authors evaluated the expression of HA family members in kidney specimens.
BJUI | 2012
Rajinikanth Ayyathurai; Michael Garcia-Roig; Michael A. Gorin; Javier González; Murugesan Manoharan; Bruce Kava; Mark S. Soloway; Gaetano Ciancio
Study Type – Therapy (case series)
BJUI | 2011
Mark S. Soloway; David Hepps; Devendar Katkoori; Rajinikanth Ayyathurai; Murugesan Manoharan
Study Type – Therapy (case series)
Urology Annals | 2012
Prashanth Kanagarajah; Rajinikanth Ayyathurai; Murugesan Manoharan; Govindarajan Narayanan; Bruce R. Kava
Adrenal tumors are among the commonest incidental findings discovered. The increased incidence of diagnosing adrenal incidentalomas is due to the widespread availability and use of noninvasive imaging studies. Extensive research has been conducted to define a cost-effective diagnostic and therapeutic protocol to guide physicians in managing incidental adrenal lesions. However, there is little consensus on the optimal management strategy. Published literature to date, describes a wide spectrum of treatment options ranging from excision of all adrenal lesions regardless of the size and functional status to extensive hormonal and radiological evaluation to avoid surgery. In this review, we present a comprehensive overview of the presentation, evaluation and management of adrenal incidentalomas. Additionally, we propose a management algorithm to optimally manage these tumors.